Stockscreener 앱 받기
1.005
5.65%
-0.0549
전일 마감가:
$1.0599
열려 있는:
$1.03
하루 거래량:
70,265
Relative Volume:
0.18
시가총액:
$4.16M
수익:
$8.97M
순이익/손실:
$-15.21M
주가수익비율:
-0.00863
EPS:
-116.51
순현금흐름:
$-10.84M
1주 성능:
+5.26%
1개월 성능:
+20.48%
6개월 성능:
-45.65%
1년 성능:
-84.13%
1일 변동 폭
$0.98
$1.0814
1주일 범위
$0.95
$1.0814
52주 변동 폭
$0.7506
$12.60
Nuwellis Inc Stock (NUWE) Company Profile
명칭
Nuwellis Inc
전화
952-345-4200
주소
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
NUWE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.00 | 4.16M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
132.13 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.36 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.62 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.46 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.32 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | ROTH MKM | Buy |
Nuwellis Inc 주식(NUWE)의 최신 뉴스
Nuwellis (NUWE) Secures Patent for Innovative Fluid Bag Design | - GuruFocus
Nuwellis, Inc. Announces Issuance of U.S. Patent No. 12,280,007 for Innovative Self-Emptying Fluid Bag Design - Nasdaq
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision - The Manila Times
Nuwellis Secures Game-Changing Patent: New Technology Slashes Clinical Workload in Critical Care - Stock Titan
Nuwellis expands IP portfolio patent in U.S. - TipRanks
Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025 | NUWE Stock News - GuruFocus
Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025 - The Manila Times
Medical Tech Earnings: Nuwellis to Reveal Q1 2025 PerformanceKey Details for Investors - Stock Titan
Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with Strategic Growth in Critical Care - GuruFocus
Nuwellis Highlights Strategic Shift to Critical Care - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips - Investing.com India
NUWE stock touches 52-week low at $0.9 amid market challenges By Investing.com - Investing.com South Africa
NUWE stock touches 52-week low at $0.9 amid market challenges - Investing.com Australia
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised) - MSN
Nuwellis, Inc. Earnings Call: Mixed Results with Promising Prospects - TipRanks
Nuwellis, Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
Nuwellis price target lowered to $13 from $16 at Roth MKM - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips By Investing.com - Investing.com South Africa
Nuwellis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Medical device maker Nuwellis posts fourth-quarter sales of $2.3 mln -March 11, 2025 at 09:08 am EDT - Marketscreener.com
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Nuwellis reports Q4 EPS (44c) vs ($54.48) last year - TipRanks
Nuwellis Earnings Show Major Medicare Win: 4X Payment Boost Coming as Critical Care Surges - StockTitan
Nuwellis (NUWE) Projected to Post Earnings on Tuesday - Defense World
Nuwellis, Inc. to Host Earnings Call - ACCESS Newswire
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO - The Manila Times
Nuwellis Appoints John Erb as Interim CEO - MSN
Nuwellis announces CEO retirement - MSN
Nuwellis Announces Retirement Of Nestor Jaramillo, Jr. As President And CEO -February 24, 2025 at 05:07 pm EST - Marketscreener.com
Nuwellis announces leadership transition with interim CEO By Investing.com - Investing.com Canada
Nuwellis announces leadership transition with interim CEO - Investing.com India
Can Nuwellis' Former CEO Steady the Ship? Key Details of Leadership Shuffle - StockTitan
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis - The Manila Times
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow Ultrafiltration Therapy in Updated AVOID-HF Study Analysis - Nasdaq
Revolutionary Heart Failure Treatment Cuts Patient Events by 60%New Study Reveals Why It Matters - StockTitan
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - The Manila Times
Nuwellis, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - Nasdaq
Nuwellis Financial Results: Strategic Update and 2024 Performance Review Coming Next Month - StockTitan
Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Rises By 67.8% - Defense World
Nuwellis (NASDAQ:NUWE) Stock Price Up 2.4% – Here’s What Happened - Defense World
Nuwellis Inc (NUWE) produces promising results - US Post News
Market Highlights: Nuwellis Inc (NUWE) Ends on a Low Note at 1.21 - The Dwinnex
Update on Alert: Extracorporeal Blood Circuit Issue from Nuwellis - FDA.gov
Nuwellis Inc (NUWE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.38%
0.17%
자본화:
|
볼륨(24시간):